Ask AI
Final Analysis of the Phase I/II BRUIN Trial of Pirtobrutinib in Patients With CLL/SLL Previously Treated with a Covalent BTKi    

Activity

Progress
1 2 3
Course Completed
Activity Information

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Released: March 26, 2026

Expiration: September 25, 2026